|
AP718A
(en)
|
|
A controlled-release pharmaceutical formulation for oral administration.
|
|
AP802A
(en)
|
|
Rapidly releasing and taste-masking pharmaceutical dosage form.
|
|
AP2815A
(en)
|
|
Compositions comprising nebivolol
|
|
AP2002002648A0
(en)
|
|
Fast dissolving orally consumable films containing an ion exhange resin as a taste masking agent.
|
|
AP2001002288A0
(en)
|
|
Methods for treatment of sickle cell anemia.
|
|
AP2010005341A0
(en)
|
|
Solid pharmaceutical dosage form
|
|
AP2001002237A0
(en)
|
|
Hydrogel-driven drug dosage form.
|
|
AP841A
(en)
|
|
Orthomolecular medical use of L-citrulline for vasoprotection, relaxative smooth muscle tone and cell protection.
|
|
AP2002002410A0
(en)
|
|
Hydrodynamically Balancing Oral Drug Delivery System
|
|
AP2007004065A0
(en)
|
|
Targeted iron chelator delivery system
|
|
AP2003002763A0
(en)
|
|
Controlled release formulations for oral administration
|
|
AP3803A
(en)
|
|
Pharmaceutical dosage form
|
|
AP3151A
(en)
|
|
Stable ready to use injectable paracetamol formulation
|
|
AP2006003602A0
(en)
|
|
Oral drug delivery system
|
|
AP2006003703A0
(en)
|
|
Pharmaceutical compositions comprising a proton pump inhibitor and a prokinetic agent
|
|
AP827A
(en)
|
|
Pharmaceutical preparation with trypanocidal qualities for veterinary use.
|
|
AP1065A
(en)
|
|
Topical preparation for introducing peptidaceous pharmacons in living organisms.
|
|
AP858A
(en)
|
|
Process for preparing solid dosage forms of very low-dose drugs.
|
|
AP2343A
(en)
|
|
Rapidly disintegrating taste-masked tablet.
|
|
AP2008004482A0
(en)
|
|
Patch
|
|
AP2007004156A0
(en)
|
|
Composition containing chitosan for sustained drugrelease
|
|
AP86A
(en)
|
|
Implant
|
|
AP2014007934A0
(en)
|
|
Taste masked dispersible tablets
|
|
AP2006003704A0
(en)
|
|
Controlled release pharmaceutical composition comprising an acid insoluble polymer and a bioadhesivepolymer
|
|
AP3204A
(en)
|
|
A controlled release intravaginal polymeric pharmaceutical dosage form
|